@a16z
  @a16z
a16z | Why Programmable Medicine Is The Future @a16z | Uploaded January 2024 | Updated October 2024, 1 hour ago.
Traditional rockets and drug development have something in common: they’re one-time use only, which makes their development more expensive and time-consuming.

However, programmable medicines that can reuse components, like gene therapy, are making great strides in revolutionizing the drug development field.

On the a16z podcast, we ask over 40 partners across a16z to preview one big idea they believe will drive innovation in 2024, including smart energy grids, voice-first companion apps, programmable medicines, AI tools for kids, and so much more.

FULL EPISODE: youtu.be/8wnNIGsIOvY

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
Why Programmable Medicine Is The FutureLearn Almost Anything from Almost AnywhereWhy The Future Of VR Is SocialHow to Build a Thriving AI Ecosystem with Lisa Su, CEO of AMDDNA Reading vs WritingCollective Action In Online CommunitiesSharks Never Stop Swimming: A Conversation with Mark CubanCrisis in Higher EdAmerica Needs More Techno-Optimism, with Marc Andreessen and Tyler CowenHow AI Is Changing User BehaviorThe Future of Longevity with Tony RobbinsLaunching a New Category with Modern Treasurys Dimitri Dadiomov

Why Programmable Medicine Is The Future @a16z

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER